Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability
Lucy Smith(University of London), Jayne Webster(London School of Hygiene & Tropical Medicine), Daniel Chandramohan(London School of Hygiene & Tropical Medicine), Brian Greenwood(London School of Hygiene & Tropical Medicine), Harry Tagbor(University of Health and Allied Sciences), Rose Odotei Adjei(Kwame Nkrumah University of Science and Technology), Caroline Jones(The University of Western Australia), Nana A Afrah(Kwame Nkrumah University of Science and Technology), Gifty Antwi(Kwame Nkrumah University of Science and Technology)
Cited by 64
Related Papers
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
|New England Journal of Medicine|1995|439
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345
Heterozygote advantage for HLA class-II type in hepatitis B virus infection
|Nature Genetics|1997|319